According to the previous analysis (Table 1 and Fig. 6), SLC12A2 was classified in cluster 8 related to demyelinating diseases, while SLC12A5 was classified in cluster 9 related to epilepsy. This evidence concerns the gene SLC12A2 and epilepsy.